<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02814448</url>
  </required_header>
  <id_info>
    <org_study_id>15-296</org_study_id>
    <secondary_id>UH2CA189883</secondary_id>
    <nct_id>NCT02814448</nct_id>
  </id_info>
  <brief_title>An Innovative Treatment for Cervical Pre Cancer</brief_title>
  <acronym>CryoPen</acronym>
  <official_title>CryoPen: An Innovative Treatment for Cervical Precancer in Low-Resource Settings</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Basic Health International</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CryoPen, Inc.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Southern California</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Albert Einstein College of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test two innovative devices, the CryoPen® and
      thermocoagulator, against gas-based cryotherapy to determine whether the novel devices
      produce equivalent or improved destruction of cervical tissue compared to gas-based
      cryotherapy. Tissue destruction with single freeze versus double freeze treatments with the
      CryoPen and gas-based cryotherapy will also be compared.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objectives of the study are to test the hypothesis that the CryoPen® and
      thermocoagulator provide a non-inferior depth of cervical tissue necrosis compared with
      traditional CO2-based cryotherapy and to test single versus double freeze applications. The
      secondary objectives of the study are to determine if the CryoPen® or thermocoagulator
      achieves a depth of necrosis of 3.5 mm, the accepted depth required for eradicating 95% of
      cervical precancer, and to observe the relationship between depth of necrosis and variations
      in cervical anatomy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Depth of Necrosis Achieved With the LMIC-adapted CryoPen and the Thermocoagulator Compared to Mean Depth of Necrosis Achieved With CO2-based Cryotherapy</measure>
    <time_frame>24-48 hours after treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean Pain During Treatment Reported by Patients Treated With Double and Single Freeze CO2 Cryotherapy, Double and Single Freeze CryoPen and Thermoablation</measure>
    <time_frame>40 seconds to 13 minutes</time_frame>
    <description>Scale Title: Pain scale during treatment Minimal value = 0 (no pain) Maximum value = 10 (most pain) This is a one item 11-point scale to measure self-reported pain during each of the treatments which lasted between 40 seconds (thermoablation) and 13 minutes (double freeze cryotherapy and double freeze CryoPen).</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">130</enrollment>
  <condition>Cervical Intraepithelial Neoplasia</condition>
  <arm_group>
    <arm_group_label>CO2 standard cryotherapy- double freeze</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Double freeze treatment consists of three-minute freeze, five-minute thaw, three-minute freeze</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CO2 standard cryotherapy- single freeze</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single freeze treatment consists of one five-minute freeze</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CryoPen- double freeze</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Double freeze treatment consists of three-minute freeze, five-minute thaw, three-minute freeze</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CryoPen- single freeze</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single freeze treatment consists of one five-minute freeze</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Thermocoagulator</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single heat application at 100 ºC for 40 seconds</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CryoPen</intervention_name>
    <description>Provides a means of freezing tissue without the use of gases or liquids</description>
    <arm_group_label>CryoPen- double freeze</arm_group_label>
    <arm_group_label>CryoPen- single freeze</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CO2 standard cryotherapy</intervention_name>
    <description>Standard therapy using carbon dioxide for freezing of tissue</description>
    <arm_group_label>CO2 standard cryotherapy- double freeze</arm_group_label>
    <arm_group_label>CO2 standard cryotherapy- single freeze</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Thermocoagulator</intervention_name>
    <description>The use of heat produced by high-frequency electric current to bring about local destruction of tissues</description>
    <arm_group_label>Thermocoagulator</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Between 25 and 65 years old.

          -  Scheduled for a hysterectomy for reasons other than cervical precancer or cancer

          -  Diagnosis of uterine, endometrial, ovarian or other cancer that does not jeopardize
             the tissue of the cervix is permitted

          -  Histological evaluation of the cervix does not interfere with the woman's current
             diagnosis

          -  Woman consents to participate after being informed about the study

          -  Normal Pap Smear or HPV test in the past 3 years

        Exclusion Criteria:

          -  Pregnancy

          -  History of cervical surgery in past 5 years

          -  Presence of cervical lesion pre-invasive or invasive on the cervix *

          -  Current Pelvic Inflammatory Disorder or severe acute cervicitis

          -  Cervix shape disfigured or hard to reach
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Miriam Cremer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital 1 de Mayo del Instituto Salvadoreño del Seguro Social</name>
      <address>
        <city>San Salvador</city>
        <country>El Salvador</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto Nacional de Enfermedades Neoplásicas</name>
      <address>
        <city>Lima</city>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>El Salvador</country>
    <country>Peru</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>June 13, 2016</study_first_submitted>
  <study_first_submitted_qc>June 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2016</study_first_posted>
  <results_first_submitted>April 23, 2018</results_first_submitted>
  <results_first_submitted_qc>October 22, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">November 20, 2018</results_first_posted>
  <last_update_submitted>October 22, 2018</last_update_submitted>
  <last_update_submitted_qc>October 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were between the ages of 25 and 65 to be eligible for the study</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>CO2 Standard Cryotherapy- Double Freeze</title>
          <description>Double freeze treatment consists of three-minute freeze, five-minute thaw, three-minute freeze
CO2 standard cryotherapy: Standard therapy using carbon dioxide for freezing of tissue</description>
        </group>
        <group group_id="P2">
          <title>CO2 Standard Cryotherapy- Single Freeze</title>
          <description>Single freeze treatment consists of one five-minute freeze
CO2 standard cryotherapy: Standard therapy using carbon dioxide for freezing of tissue</description>
        </group>
        <group group_id="P3">
          <title>CryoPen- Double Freeze</title>
          <description>Double freeze treatment consists of three-minute freeze, five-minute thaw, three-minute freeze
CryoPen: Provides a means of freezing tissue without the use of gases or liquids</description>
        </group>
        <group group_id="P4">
          <title>CryoPen- Single Freeze</title>
          <description>Single freeze treatment consists of one five-minute freeze
CryoPen: Provides a means of freezing tissue without the use of gases or liquids</description>
        </group>
        <group group_id="P5">
          <title>Thermocoagulator</title>
          <description>Single heat application at 100 ºC for 40 seconds
Thermocoagulator: The use of heat produced by high-frequency electric current to bring about local destruction of tissues</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="24"/>
                <participants group_id="P3" count="26"/>
                <participants group_id="P4" count="25"/>
                <participants group_id="P5" count="28"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="24"/>
                <participants group_id="P3" count="25"/>
                <participants group_id="P4" count="25"/>
                <participants group_id="P5" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>CO2 Standard Cryotherapy- Double Freeze</title>
          <description>Double freeze treatment consists of three-minute freeze, five-minute thaw, three-minute freeze
CO2 standard cryotherapy: Standard therapy using carbon dioxide for freezing of tissue</description>
        </group>
        <group group_id="B2">
          <title>CO2 Standard Cryotherapy- Single Freeze</title>
          <description>Single freeze treatment consists of one five-minute freeze
CO2 standard cryotherapy: Standard therapy using carbon dioxide for freezing of tissue</description>
        </group>
        <group group_id="B3">
          <title>CryoPen- Double Freeze</title>
          <description>Double freeze treatment consists of three-minute freeze, five-minute thaw, three-minute freeze
CryoPen: Provides a means of freezing tissue without the use of gases or liquids</description>
        </group>
        <group group_id="B4">
          <title>CryoPen- Single Freeze</title>
          <description>Single freeze treatment consists of one five-minute freeze
CryoPen: Provides a means of freezing tissue without the use of gases or liquids</description>
        </group>
        <group group_id="B5">
          <title>Thermocoagulator</title>
          <description>Single heat application at 100 ºC for 40 seconds
Thermocoagulator: The use of heat produced by high-frequency electric current to bring about local destruction of tissues</description>
        </group>
        <group group_id="B6">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="27"/>
            <count group_id="B2" value="24"/>
            <count group_id="B3" value="26"/>
            <count group_id="B4" value="25"/>
            <count group_id="B5" value="28"/>
            <count group_id="B6" value="130"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="26"/>
                    <measurement group_id="B4" value="25"/>
                    <measurement group_id="B5" value="28"/>
                    <measurement group_id="B6" value="130"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45.46" spread="6.44"/>
                    <measurement group_id="B2" value="45.5" spread="6.53"/>
                    <measurement group_id="B3" value="45.92" spread="5.82"/>
                    <measurement group_id="B4" value="44.65" spread="5.91"/>
                    <measurement group_id="B5" value="45.35" spread="6.05"/>
                    <measurement group_id="B6" value="45.37" spread="5.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="26"/>
                    <measurement group_id="B4" value="25"/>
                    <measurement group_id="B5" value="28"/>
                    <measurement group_id="B6" value="130"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>El Salvador</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="15"/>
                    <measurement group_id="B5" value="18"/>
                    <measurement group_id="B6" value="79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Peru</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="10"/>
                    <measurement group_id="B5" value="10"/>
                    <measurement group_id="B6" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mean Depth of Necrosis Achieved With the LMIC-adapted CryoPen and the Thermocoagulator Compared to Mean Depth of Necrosis Achieved With CO2-based Cryotherapy</title>
        <time_frame>24-48 hours after treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CO2 Standard Cryotherapy- Double Freeze</title>
            <description>Double freeze treatment consists of three-minute freeze, five-minute thaw, three-minute freeze
CO2 standard cryotherapy: Standard therapy using carbon dioxide for freezing of tissue</description>
          </group>
          <group group_id="O2">
            <title>CO2 Standard Cryotherapy- Single Freeze</title>
            <description>Single freeze treatment consists of one five-minute freeze
CO2 standard cryotherapy: Standard therapy using carbon dioxide for freezing of tissue</description>
          </group>
          <group group_id="O3">
            <title>CryoPen- Double Freeze</title>
            <description>Double freeze treatment consists of three-minute freeze, five-minute thaw, three-minute freeze
CryoPen: Provides a means of freezing tissue without the use of gases or liquids</description>
          </group>
          <group group_id="O4">
            <title>CryoPen- Single Freeze</title>
            <description>Single freeze treatment consists of one five-minute freeze
CryoPen: Provides a means of freezing tissue without the use of gases or liquids</description>
          </group>
          <group group_id="O5">
            <title>Thermocoagulator</title>
            <description>Single heat application at 100 ºC for 40 seconds
Thermocoagulator: The use of heat produced by high-frequency electric current to bring about local destruction of tissues</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Depth of Necrosis Achieved With the LMIC-adapted CryoPen and the Thermocoagulator Compared to Mean Depth of Necrosis Achieved With CO2-based Cryotherapy</title>
          <units>millimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="25"/>
                <count group_id="O4" value="25"/>
                <count group_id="O5" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.0" spread="1.6"/>
                    <measurement group_id="O2" value="5.6" spread="1.9"/>
                    <measurement group_id="O3" value="5.3" spread="1.2"/>
                    <measurement group_id="O4" value="5.5" spread="1.3"/>
                    <measurement group_id="O5" value="3.5" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Pain During Treatment Reported by Patients Treated With Double and Single Freeze CO2 Cryotherapy, Double and Single Freeze CryoPen and Thermoablation</title>
        <description>Scale Title: Pain scale during treatment Minimal value = 0 (no pain) Maximum value = 10 (most pain) This is a one item 11-point scale to measure self-reported pain during each of the treatments which lasted between 40 seconds (thermoablation) and 13 minutes (double freeze cryotherapy and double freeze CryoPen).</description>
        <time_frame>40 seconds to 13 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CO2 Standard Cryotherapy- Double Freeze</title>
            <description>Double freeze treatment consists of three-minute freeze, five-minute thaw, three-minute freeze
CO2 standard cryotherapy: Standard therapy using carbon dioxide for freezing of tissue</description>
          </group>
          <group group_id="O2">
            <title>CO2 Standard Cryotherapy- Single Freeze</title>
            <description>Single freeze treatment consists of one five-minute freeze
CO2 standard cryotherapy: Standard therapy using carbon dioxide for freezing of tissue</description>
          </group>
          <group group_id="O3">
            <title>CryoPen- Double Freeze</title>
            <description>Double freeze treatment consists of three-minute freeze, five-minute thaw, three-minute freeze
CryoPen: Provides a means of freezing tissue without the use of gases or liquids</description>
          </group>
          <group group_id="O4">
            <title>CryoPen- Single Freeze</title>
            <description>Single freeze treatment consists of one five-minute freeze
CryoPen: Provides a means of freezing tissue without the use of gases or liquids</description>
          </group>
          <group group_id="O5">
            <title>Thermocoagulator</title>
            <description>Single heat application at 100 ºC for 40 seconds
Thermocoagulator: The use of heat produced by high-frequency electric current to bring about local destruction of tissues</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Pain During Treatment Reported by Patients Treated With Double and Single Freeze CO2 Cryotherapy, Double and Single Freeze CryoPen and Thermoablation</title>
          <description>Scale Title: Pain scale during treatment Minimal value = 0 (no pain) Maximum value = 10 (most pain) This is a one item 11-point scale to measure self-reported pain during each of the treatments which lasted between 40 seconds (thermoablation) and 13 minutes (double freeze cryotherapy and double freeze CryoPen).</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="25"/>
                <count group_id="O4" value="25"/>
                <count group_id="O5" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2" spread="1.0"/>
                    <measurement group_id="O2" value="1.8" spread="0.8"/>
                    <measurement group_id="O3" value="2.5" spread="1.4"/>
                    <measurement group_id="O4" value="2.6" spread="1.4"/>
                    <measurement group_id="O5" value="4.1" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>CO2 Standard Cryotherapy- Double Freeze</title>
          <description>Double freeze treatment consists of three-minute freeze, five-minute thaw, three-minute freeze
CO2 standard cryotherapy: Standard therapy using carbon dioxide for freezing of tissue</description>
        </group>
        <group group_id="E2">
          <title>CO2 Standard Cryotherapy- Single Freeze</title>
          <description>Single freeze treatment consists of one five-minute freeze
CO2 standard cryotherapy: Standard therapy using carbon dioxide for freezing of tissue</description>
        </group>
        <group group_id="E3">
          <title>CryoPen- Double Freeze</title>
          <description>Double freeze treatment consists of three-minute freeze, five-minute thaw, three-minute freeze
CryoPen: Provides a means of freezing tissue without the use of gases or liquids</description>
        </group>
        <group group_id="E4">
          <title>CryoPen- Single Freeze</title>
          <description>Single freeze treatment consists of one five-minute freeze
CryoPen: Provides a means of freezing tissue without the use of gases or liquids</description>
        </group>
        <group group_id="E5">
          <title>Thermocoagulator</title>
          <description>Single heat application at 100 ºC for 40 seconds
Thermocoagulator: The use of heat produced by high-frequency electric current to bring about local destruction of tissues</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="28"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="28"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="28"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Miriam Cremer</name_or_title>
      <organization>Cleveland Clinic</organization>
      <phone>216-312-0618</phone>
      <email>cremerm@ccf.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

